TW200515914A - Compositions containing an active fraction isolated from Lycium barbarum and methods of using the same - Google Patents

Compositions containing an active fraction isolated from Lycium barbarum and methods of using the same

Info

Publication number
TW200515914A
TW200515914A TW092131436A TW92131436A TW200515914A TW 200515914 A TW200515914 A TW 200515914A TW 092131436 A TW092131436 A TW 092131436A TW 92131436 A TW92131436 A TW 92131436A TW 200515914 A TW200515914 A TW 200515914A
Authority
TW
Taiwan
Prior art keywords
lycium barbarum
methods
same
compositions containing
active fraction
Prior art date
Application number
TW092131436A
Other languages
English (en)
Inventor
Kin-Ping Wong
Ming-Chung Wong
Original Assignee
Wackvom Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wackvom Ltd filed Critical Wackvom Ltd
Publication of TW200515914A publication Critical patent/TW200515914A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW092131436A 2002-11-08 2003-11-10 Compositions containing an active fraction isolated from Lycium barbarum and methods of using the same TW200515914A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US42514402P 2002-11-08 2002-11-08

Publications (1)

Publication Number Publication Date
TW200515914A true TW200515914A (en) 2005-05-16

Family

ID=32312934

Family Applications (1)

Application Number Title Priority Date Filing Date
TW092131436A TW200515914A (en) 2002-11-08 2003-11-10 Compositions containing an active fraction isolated from Lycium barbarum and methods of using the same

Country Status (5)

Country Link
US (1) US8226988B2 (zh)
CN (1) CN100594919C (zh)
AU (1) AU2003287100A1 (zh)
TW (1) TW200515914A (zh)
WO (1) WO2004043346A2 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003287100A1 (en) 2002-11-08 2004-06-03 Kin-Ping Wong Compositions containing an active fraction isolated from lycium barbarum and methods of using the same
ITMI20041631A1 (it) * 2004-08-06 2004-11-06 Indena Spa Uso di piante medicinalime di loro estratti come promotori della crescita in veterinaria e zootecnia
EP2036568A1 (en) * 2007-09-12 2009-03-18 Nestec S.A. Wolfberries and inflammation
CN102112143A (zh) * 2008-07-30 2011-06-29 雀巢产品技术援助有限公司 预防、减少或治疗由缺血和类缺血病症引起的损害的方法和组合物
TW201021821A (en) * 2008-12-10 2010-06-16 Fl Dauern Res Inc Formulations and methods for maintaining normal levels of catecholamines, glucocorticoids, androsteroids and their related hormones
KR101067443B1 (ko) * 2009-06-23 2011-09-27 여오영 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물
WO2019173482A1 (en) * 2018-03-06 2019-09-12 Sanford Burnham Prebys Medical Discovery Institute 4-aminoquinoline compounds for the treatment of angiogenesis
CN112391430B (zh) * 2019-08-14 2022-12-30 上海医药工业研究院 一种用于生产平阳霉素的发酵培养基及发酵方法
CN111658740B (zh) * 2020-06-19 2021-09-14 南京中医药大学 具有改善年龄相关性黄斑变性的药食两用组合物及其制备方法与应用
CN114437244B (zh) * 2021-12-30 2023-02-07 中国科学院兰州化学物理研究所 一种具有抗肺癌a549细胞增殖功能的枸杞多糖提取物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
US5525626A (en) * 1989-11-24 1996-06-11 Schaper & Bruemmer Gmbh & Co. Treating susceptible human malignant tumors with 7-hydroxy-1,2-benzopyrone
US5595756A (en) * 1993-12-22 1997-01-21 Inex Pharmaceuticals Corporation Liposomal compositions for enhanced retention of bioactive agents
US7132458B2 (en) * 1994-08-10 2006-11-07 Chemaphor Inc. Oxidized carotenoid fractions and ketoaldehyde useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents
WO2004043345A2 (en) 2002-11-08 2004-05-27 Kin-Ping Wong Extract of trapa natans and methods of using the same
AU2003287100A1 (en) 2002-11-08 2004-06-03 Kin-Ping Wong Compositions containing an active fraction isolated from lycium barbarum and methods of using the same
US20080124416A1 (en) 2006-11-28 2008-05-29 Renaissance Herbs, Inc. Therapeutic composition from goji (lycium barbarum l.), methods of making and using

Also Published As

Publication number Publication date
AU2003287100A1 (en) 2004-06-03
US20050281902A1 (en) 2005-12-22
WO2004043346A2 (en) 2004-05-27
US8226988B2 (en) 2012-07-24
CN1741806A (zh) 2006-03-01
AU2003287100A8 (en) 2004-06-03
WO2004043346A3 (en) 2004-09-30
CN100594919C (zh) 2010-03-24

Similar Documents

Publication Publication Date Title
MXPA06012500A (es) Compuestos para el tratamiento de la enfermedad de alzheimer y para la inhibicion de la produccion del peptido beta-amiloideo.
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
ATE365045T1 (de) Vermehrung des weich- sowie des knochengewebes anhand von aus muskeln stammenden vorläuferzellen,sowie damit verbundene zusammensetzungen und behandlungsformen
WO2007089584A3 (en) Compositions and their uses directed to huntingtin
WO2003089619A3 (en) Placental derived stem cells and uses thereof
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
WO2006066244A3 (en) Method for extending lifespan and delaying the onset of age-related disease
MX2007004551A (es) Compuestos tiadiazol y metodos de uso.
WO2003061591A3 (en) Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis
BR0314699A (pt) Composto, composição e métodos para o tratamento da dor e para inibição da função vr1 em uma célula
NO20051426L (no) Behandling av melanom ved reduksjon i clusterin-nivaer
WO2005032494A3 (en) Lpa receptor agonists and antagonists and methods of use
TW200515914A (en) Compositions containing an active fraction isolated from Lycium barbarum and methods of using the same
MY134562A (en) Methods and compositions to treat conditions associated with neovascularization
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
HK1205677A1 (zh) 間葉幹細胞及其用法
WO2009117828A8 (en) Saponin extract from saponaria spp. and uses thereof
BR0012175A (pt) Antagonistas de receptor de igiur5, seletivos para o tratamento de enxaqueca
AU7548500A (en) Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents
WO2002007749A3 (en) Device providing regulated growth factor delivery for the regeneration of peripheral nerves
MX2007004514A (es) Formas cristalinas de 3-[5-cloro-4-[(2,4-difluorobencil)oxi]-6 oxopirimidin-1(6h)-il]-n-(2-hidroxetil)-4-metilbenzamida.
TW200515915A (en) Extract of Trapa natans and methods of using the same
Ghafouri‐Fard et al. Antioxidant therapy against TGF‐β/SMAD pathway involved in organ fibrosis
IL126175A (en) Pharmaceutical compositions containing endothelin antagonists and novel endothelin antagonists
WO2003024402A3 (en) Lpa receptor agonists and antagonists and methods of use